ArticleNeurology and therapy2024

Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.

Takao Takeshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.